First phase of unit recommissioning complete, PowerHouse says

Josh White WebFG News | 21 Apr, 2017 14:43 | | |

calculatrice-et-trombones-comptes-entrepreneurs-entreprises-argent-finances-tpe-pme-entreprenariat-finances-banques-startup-business-plan-argent

Powerhouse Energy Group

0.70

17:18 11/12/17
-6.67%
-0.05
  • 9,543.26
  • 0.30%28.68
  • Max: 9,558.75
  • Min: 9,514.19
  • Volume: 0
  • MM 200 : n/a
17:30 11/12/17
  • 1,017.18
  • 0.04%0.36
  • Max: 1,021.36
  • Min: 1,016.52
  • Volume: 0
  • MM 200 : n/a
17:20 11/12/17

Ultra high temperature gasification waste to energy systems company PowerHouse Energy Group announced on Friday that the first phase of the re-commissioning of the its G3-UHt unit had been completed, with the successful production of gas from the system.

The AIM-traded firm said the G3-UHt unit operated at a temperature of over 1000 degrees Celsius, demonstrating its capacity to gasify any historically difficult waste material and generate synthesis gas.

“As previously announced, the G3-UHt will now be moved to the Thornton Science Park, operated by the University of Chester, with PowerHouse establishing its offices at the Energy Centre of the Park immediately thereafter,” the PowerHouse board said in a statement.

It said the re-commissioning effort had been assisted by OrePro of Brisbane, Australia, EngSolv of Wales, and Waste2tricity, and had allowed the company to begin commercial development enhancements, automation of the control systems, and commence the rigorous process of a Hazard and Operability Study (HAZOP) and a Hazard Identification Study (HAZID).

Upon successful completion, the company said it will gain the British Health Safety & Environmental certifications necessary to operate the unit at the Thornton Science Park at full capacity.

The board added that it anticipated several external cosmetic improvements would be made to the G3-UHt unit over the coming period and would continue the development of its automation processes at its new facility on the Science Park.

Rather than operate from a container, as previously anticipated, PowerHouse negotiated a two-year lease of a purpose-built emission laboratory / test facility at Thornton, where the G3-UHt unit would be installed.

“This is the day the team has been working on for nearly two years,” said executive chairman Keith Allaun.

“The successful re-commissioning of the G3-UHt unit, here in the UK, represents the starting point of our journey to commercialisation.

“Our relationship with the engineering department at the University of Chester continues to expand and strengthen, and the support of the Thornton Science Park has been extraordinary.”

Allaun quipped that he could not have imagined a “more ideal and synergistic” relationship with the university.

“Our mutual interests in Thermal Molecular Conversion at ultra-high temperatures provide a research platform for the expansion of the university’s curriculum, and the development of a graduate research program utilising the G3-UHt platform.”

More news

07:50 Aggreko confirms timeline for Drewett as new CFO

Aggreko gave a timeline to the appointment of its new chief financial officer on Tuesday, confirming that Heath Drewett would take up the role on 3 January.

07:44 Glencore shareholders to receive upbeat investor update

Glencore shareholders are set to be told of the company’s position as the “leading producer” of tier 1 commodities - that is, copper, cobalt, nickel, zinc and thermal coal - during an investor update set down for Tuesday afternoon.

07:42 Westfield shopping centres to be bought by France's Unibail-Rodamco

Shopping centre owner Westfield has accepted a takeover offer from European rival Unibail-Rodamco, a week after the pair's UK rivals agreed a similar merger.

07:41 London pre-open: Stocks to open higher ahead of inflation data

London stocks were set for a positive open on Tuesday following an upbeat session in the US, as investors eye the release of key UK inflation data.

07:33 GlaxoSmithKline upbeat on 'promising' new data from DREAMM-1 study

GlaxoSmithKline has presented promising new data from the dose expansion phase of the DREAMM-1 study of GSK2857916, an investigational anti-B-cell maturation antigen (BCMA) antibody-drug conjugate.

07:28 Hurricane clean-up boosts Ashtead at half-year, Indivior schizophrenia treatment accepted for FDA review

London open

07:20 Indivior's schizophrenia drug application accepted by US FDA

A one-monthly schizophrenia treatment developed by heroin-addiction specialist Indivior has been accepted for review by the US drug regulator.

07:07 Tuesday newspaper round-up: Trump tax warning, oil pipeline, Comcast, wages

Philip Hammond has joined other EU treasury ministers in warning President Trump about tax plans that they say would breach international agreements and hammer the City of London. In a letter they express “significant concerns” that the Trump administration’s tax plans would have a “major distortive impact on international trade”. - The Times

11 Dec US close: Markets continue run further into record territory

Markets in the US pushed further into record territory on Monday, as investors eyed a rate announcement from the Federal Reserve later in the week.

11 Dec Tuesday preview: November CPI, Ashtead results in focus

All eyes will be on the November CPI report on Tuesday which hopefully - for the Bank of England governor - will show the rate of increase in the cost of living stuck at 3.0%, allowing him to avoid having to pen a letter to the Chancellor explaining why he has allowed inflation to err more than 1.0 percentage above the Bank of England's target.